Evidence map›Paper›PMID 34011680›Full record

ArticlemSphere2021

Emergence of

David A Boyd, Laura F Mataseje, Tanis Dingle, Linda Hoang, Brigitte Lefebvre, Allison McGeer, Roberto G Melano, Ian Stuart, Andrew Walkty, Amanda Wilmer and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 1 country.

David A BoydAntimicrobial Resistance & Nosocomial Infections, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada david.boyd@canada.ca.ORCID 0000-0001-8618-4848
Laura F MatasejeAntimicrobial Resistance & Nosocomial Infections, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Tanis DingleUniversity of Alberta, Provincial Laboratory for Public Health, Edmonton, Alberta, Canada.
Linda HoangBacteriology & Mycology, BCCDC Public Health Laboratory, Vancouver, British Columbia, Canada.
Brigitte LefebvreLaboratoire de Santé Publique du Québec, Institut National de Santé Publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada.
Allison McGeerDepartment of Microbiology, Mount Sinai Hospital, Toronto, Ontario, Canada.
Roberto G MelanoPublic Health Ontario Laboratories, Toronto, Ontario, Canada.ORCID 0000-0002-0268-1028
Ian StuartHorizon Health Network, Fredricton, New Brunswick, Canada.
Andrew WalktyDepartments of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0003-2880-2104
Amanda WilmerDepartment of Laboratory Medicine, Kelowna General Hospital, Kelowna, British Columbia, Canada.
Michael R MulveyAntimicrobial Resistance & Nosocomial Infections, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Public Health Agency of Canada · CABC Centre for Disease Control · CAHorizon Health Network · CAInstitut National de Santé Publique du Québec · CAKelowna General Hospital · CAMount Sinai Hospital · CAToronto Public Health · CAUniversity of Alberta · CAUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2018 to 2019, PCR for carbapenemases in routine Gram-negative isolates submitted to the National Microbiology Laboratory revealed an increase in IMP-type metalloenzyme-positive isolates, mostly among

Indexed as

PhylogenyAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCanadaCarbapenemsCross InfectionEnterobacteriaceaeEnterobacteriaceae InfectionsHumansMicrobial Sensitivity TestsPlasmidsWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsantimicrobial resistancemetallo-beta-lactamaseMorganellaceae

Identifiers

PMID34011680
PMCPMC8265620
OpenAlexW3160307304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.